VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
-13.71%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$96.9M
AUM Growth
+$96.9M
(-40%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-13.44%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
$6.77M |
Sector Composition
| 1 | Healthcare | 25.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNA
1
Verona Pharma
VRNA
$9.16B
| $12M | 12.33% | 875,000 | – | – |
|
2
VYNE Therapeutics
VYNE
$8.16M
| $11.9M | 12.24% | 1,461,552 | – | – |
|
|
NBRV
3
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $619K | 0.64% | 177,957 -1,945,005 | -92% | -$6.77M |
|